Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi

Talk Details · IOC 2027

Conjunctival reactive lymphoid hyperplasia mimicking a lymphoproliferative lesion in a 12-year-old atopic child: A case report

Oral · Virtual · Day 3

Abstract

About this talk

Introduction: Reactive lymphoid hyperplasia (RLH) is a benign polyclonal lymphoproliferative disorder of the ocular adnexa. Conjunctival involvement is uncommon in children and is clinically indistinguishable from ocular adnexal lymphoma, so histopathology and immunohistochemistry are required for diagnosis.

Case presentation: A 12-year-old boy presented with an 8-month history of a persistent lesion of the right conjunctiva, first noticed in September 2025 and preceded by about two months of ocular redness. He reported no pain, visual loss or systemic symptoms. His history included post-term birth (42 weeks), atopy (house dust mite and floral pollen allergy) and asthma treated with budesonide/formoterol (Symbicort), with no attack during the previous year. There was no consanguinity or relevant family history.

Examination of the right eye showed salmon-pink, slightly elevated, subepithelial-looking conjunctival patches on the bulbar conjunctiva, predominantly in the temporal and inferior sectors, with fine overlying vessels. There was no subconjunctival hemorrhage and no obvious corneal involvement. The lesion was chronic, focal and unilateral. The fundus and the left eye were normal.

Given the persistent unilateral salmon-patch appearance, a lymphoid lesion was suspected and a diagnostic conjunctival biopsy was performed. Immunohistochemistry showed a mixed B- and T-cell population: CD20, CD79a, CD3, CD5 and bcl-2 were positive, and CD10 was negative. IgG4 staining was positive. The Ki-67 proliferation index ranged from 2% to 20%. Together with the histology, these findings supported reactive lymphoid hyperplasia and excluded lymphoma. Thoraco-abdomino-pelvic contrast-enhanced CT was normal, showing no lymphadenopathy or systemic disease.

Management: Management was based on the benign diagnosis. The biopsy was the key diagnostic step and, when complete, also removed the lesion. The systemic work-up was reassuring, so no chemotherapy, radiotherapy or immunotherapy was needed. Treatment of the ocular surface and of the allergic background (topical anti-inflammatory therapy and control of allergic triggers) was considered to limit recurrence. Regular clinical follow-up with slit-lamp examination was planned to detect recurrence or, rarely, progression to lymphoma. The family was advised to return promptly if the lesion reappeared or enlarged.

Discussion: Conjunctival RLH typically appears as a salmon-pink lesion, the same appearance as ocular adnexal lymphoma, hence the diagnostic challenge. The mixed B- and T-cell phenotype, the absence of CD10, the variable Ki-67 index and normal imaging argue for a reactive process. Atopy may have contributed through chronic antigenic stimulation. IgG4 positivity does not by itself indicate IgG4-related disease and should be interpreted with the clinical picture.

Conclusion: A persistent salmon-pink conjunctival lesion in a child should prompt biopsy with immunohistochemistry. In this atopic child the diagnosis was reactive lymphoid hyperplasia, and management consisted of biopsy, systemic work-up and close follow-up.

Speaker

About the speaker

Adel Hajjaji

Adel Hajjaji

Military Hospital Moulay Ismail of Meknes, Morocco

View full speaker profile →

Join the IOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us